Marcus Kelly
19Patents
4h-index
16Co-inventors
49Inventor score
Filing activity: Aug 20, 2014 → Dec 22, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10738130B2 | Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof | Physics | 38 | Active |
| US9302015B2 | Anti-PRLR antibodies and methods for killing PRLR-expressing cells | Chemistry; Metallurgy | 22 | Active |
| US9475875B2 | Anti-EGFRvIII antibodies and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US9545451B2 | Anti-PRLR antibodies and methods for killing PRLR-expressing cells | Chemistry; Metallurgy | 4 | Active |
| US10736976B2 | Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging | Chemistry; Metallurgy | 3 | Active |
| US10905784B2 | Radiolabeled anti-LAG3 antibodies for immuno-PET imaging | Chemistry; Metallurgy | 3 | Active |
| US10738124B2 | Anti-EGFRvIII antibodies and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US9688764B2 | Methods of treating breast cancer by administering anti-human prolactin receptor (PRLR) antibodies | Chemistry; Metallurgy | 2 | Active |
| US10047160B2 | Anti-EGFRvIII antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10941208B2 | Anti-MUC16 antibodies | Physics | 1 | Active |
| US10925971B2 | Methods of treating PRLR positive breast cancer | Chemistry; Metallurgy | 1 | Active |
| US10106616B2 | Antagonist antibodies to human prolactin receptor (PRLR) | Chemistry; Metallurgy | 1 | Active |
| US12144864B2 | Tubulysins and protein-tubulysin conjugates | Chemistry; Metallurgy | 0 | Active |
| US11608380B2 | Anti-EGFRvIII antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11511001B2 | Radiolabeled anti-LAG3 antibodies for immuno-PET imaging | Chemistry; Metallurgy | 0 | Active |
| US11485793B2 | Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind MUC16 and CD3, and uses thereof | Physics | 0 | Active |
| US10683354B2 | Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods of use thereof to kill PRLR-expressing cells | Chemistry; Metallurgy | 0 | Active |
| US12053534B2 | Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging | Chemistry; Metallurgy | 0 | Active |
| US11896682B2 | Radiolabeled MET binding proteins for immuno-PET imaging and methods of use thereof | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.